CD14 and serum lipopolysaccharide activity: In a human endotoxemia model, endotoxin treatment increased the frequency of non-classical CD14+CD16+ monocytes in the blood, due to endotoxin-mediated conversion of circulating classical CD14highCD16− monocytes into CD14+CD16+ monocytes42.